MR-Guided HDR Brachytherapy Boost in Localized Prostate Cancer Results of a Phase II Trial

被引:0
|
作者
Johnny, C. [1 ]
Berlin, A. [2 ]
Weersink, R. A. [2 ]
Raman, S. [2 ]
Glicksman, R. [2 ]
Catton, C. [1 ]
Rink, A. [1 ]
Warde, P. R. [3 ]
Lao, B. [4 ]
Menard, C. [5 ]
Chung, P. [2 ]
机构
[1] Univ Hlth Network, Radiat Med Program, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Radiat Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[4] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Ctr Hosp Univ Montreal CHUM, Montreal, PQ, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2870
引用
收藏
页码:E397 / E397
页数:1
相关论文
共 50 条
  • [1] Comparison of CT-guided and MR-guided HDR brachytherapy for prostate cancer
    Haverkamp, U
    Prümer, BA
    Krause, K
    Tschuschke, C
    Blumberg, J
    Benkel, P
    Fischedick, AR
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 118 - 119
  • [2] MR-guided HDR prostate brachytherapy with teleoperated steerable needles
    de Vries, M.
    Wijntjes, M.
    Sikorski, J.
    Moreira, P.
    van de Berg, N. J.
    van den Dobbelsteen, J. J.
    Misra, S.
    [J]. JOURNAL OF ROBOTIC SURGERY, 2023, 17 (05) : 2461 - 2469
  • [3] MR-guided HDR prostate brachytherapy with teleoperated steerable needles
    M. de Vries
    M. Wijntjes
    J. Sikorski
    P. Moreira
    N. J. van de Berg
    J. J. van den Dobbelsteen
    S. Misra
    [J]. Journal of Robotic Surgery, 2023, 17 : 2461 - 2469
  • [4] Open MR-Guided High-Dose-Rate (HDR) Prostate Brachytherapy: Feasibility and Initial Experiences Open MR-Guided High-Dose-Rate (HDR) Prostate Brachytherapy
    Lakosi, Ferenc
    Antal, Gergely
    Vandulek, Csaba
    Kovacs, Arpad
    Toller, Gabor L.
    Rakasz, Istvan
    Bajzik, Gabor
    Hadjiev, Janaki
    Bogner, Peter
    Repa, Imre
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (02) : 315 - 324
  • [5] Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results
    Pujol, N.
    Pace-Loscos, T.
    Schiappa, R.
    Gautier, M.
    Chand, M. E.
    Levi, J. M. Hannoun
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E242 - E242
  • [6] Updated prospective study of MR-guided focal salvage HDR brachytherapy for recurrent prostate cancer
    Chung, H.
    Corkum, M.
    Loblaw, A.
    Tseng, C.
    Murgic, J.
    Ravi, A.
    Davidson, M.
    Wronski, M.
    Haider, M.
    Morton, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1123 - S1123
  • [7] Predicting biochemical failure after MR-guided focal HDR brachytherapy for recurrent prostate cancer
    Willigenburg, T.
    van Son, M.
    van de Pol, S.
    Eppinga, W.
    Lagendijk, J.
    Moerland, M.
    de Boer, H.
    van Zyp, J. van der Voort
    Peters, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S25 - S27
  • [8] Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer
    Dincer, Neris
    Ugurluer, Gamze
    Mustafayev, Teuta Zoto
    Serkizyan, Anatolia
    Aydin, Gokhan
    Gungor, Gorkem
    Yapici, Bulent
    Atalar, Banu
    Ozyar, Enis
    [J]. BRACHYTHERAPY, 2024, 23 (01) : 18 - 24
  • [9] Preliminary Results Of MR-Guided Brachytherapy Boost To External Beam Radiotherapy For Intermediate And High Risk Prostate Cancer
    Fong, C. H.
    Padayachee, J.
    Liu, Z.
    Weiss, J.
    Lao, B.
    Gumapac, N.
    Bettoli, P.
    Sanmamed, N. S.
    Rink, A.
    Weersink, R. A.
    Bayley, A.
    Raman, S.
    Helou, J.
    Catton, C.
    Warde, P.
    Berlin, A.
    Menard, C.
    Chung, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E906 - E906
  • [10] A Prospective Study of MR-guided Focal Salvage HDR Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients
    Chung, Hans
    Corkum, Mark
    Loblaw, Andrew
    Tseng, Chia-Lin
    Ravi, Ananth
    Davidson, Melanie
    Wronski, Matt
    Haider, Masoom
    Morton, Gerard
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S60 - S60